149 related articles for article (PubMed ID: 15770434)
1. Autonomic effects of nebivolol versus atenolol in healthy subjects.
Chiladakis JA; Georgiopoulou E; Alexopoulos D
Cardiovasc Drugs Ther; 2004 Nov; 18(6):469-73. PubMed ID: 15770434
[TBL] [Abstract][Full Text] [Related]
2. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
Nuttall SL; Routledge HC; Kendall MJ
J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial.
Grassi G; Trevano FQ; Facchini A; Toutouzas T; Chanu B; Mancia G
Blood Press Suppl; 2003 Dec; 2():35-40. PubMed ID: 14761075
[TBL] [Abstract][Full Text] [Related]
4. Acute effects of third generation β-blockers on short-term and beat-to-beat blood pressure variability in sinoaortic-denervated rats.
Bertera FM; Del Mauro JS; Lovera V; Chiappetta D; Polizio AH; Taira CA; Höcht C
Hypertens Res; 2013 Apr; 36(4):349-55. PubMed ID: 23364340
[TBL] [Abstract][Full Text] [Related]
5. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
[TBL] [Abstract][Full Text] [Related]
6. Clinical pharmacodynamics of nebivolol: new evidence of nitric oxide-mediated vasodilating activity and peculiar haemodynamic properties in hypertensive patients.
Zanchetti A
Blood Press Suppl; 2004 Oct; 1():17-32. PubMed ID: 15587108
[TBL] [Abstract][Full Text] [Related]
7. Heart rate variability after acute myocardial infarction in patients treated with atenolol and metoprolol.
Lurje L; Wennerblom B; Tygesen H; Karlsson T; Hjalmarson A
Int J Cardiol; 1997 Jul; 60(2):157-64. PubMed ID: 9226286
[TBL] [Abstract][Full Text] [Related]
8. Beta-blockers reduce aortic stiffness in hypertension but nebivolol, not atenolol, reduces wave reflection.
Mahmud A; Feely J
Am J Hypertens; 2008 Jun; 21(6):663-7. PubMed ID: 18437130
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of effects of nebivolol and atenolol on P-wave dispersion in patients with hypertension].
Tuncer M; Fettser DV; Gunes Y; Batyraliev TA; Guntekin U; Gumrukchuoglu KhA; Eryonucu B; Guler N; Sidorenko BA
Kardiologiia; 2008; 48(4):42-5. PubMed ID: 18447840
[TBL] [Abstract][Full Text] [Related]
10. Standardized tests of heart rate variability for autonomic function tests in healthy Koreans.
Park SB; Lee BC; Jeong KS
Int J Neurosci; 2007 Dec; 117(12):1707-17. PubMed ID: 17987472
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of nebivolol in man.
Van Bortel LM; de Hoon JN; Kool MJ; Wijnen JA; Vertommen CI; Van Nueten LG
Eur J Clin Pharmacol; 1997; 51(5):379-84. PubMed ID: 9049578
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of conventional B-blockers and nebivolol on psychomotor performances in healthy volunteers: a preliminary report.
Kumar A; Khajuria V; Tandon VR; Kapoor B; Singh R
Indian J Physiol Pharmacol; 2007; 51(2):183-8. PubMed ID: 18175665
[TBL] [Abstract][Full Text] [Related]
13. Effects of nebivolol, atenolol and propranolol on in vivo cardiovascular and metabolic responses to isoproterenol in dogs.
Bowden CR; Marchione CS
J Pharmacol Exp Ther; 1989 Nov; 251(2):599-605. PubMed ID: 2572694
[TBL] [Abstract][Full Text] [Related]
14. Nebivolol: new therapy update.
Sule SS; Frishman W
Cardiol Rev; 2006; 14(5):259-64. PubMed ID: 16924166
[TBL] [Abstract][Full Text] [Related]
15. The combination of nebivolol plus pravastatin is associated with a more beneficial metabolic profile compared to that of atenolol plus pravastatin in hypertensive patients with dyslipidemia: a pilot study.
Rizos E; Bairaktari E; Kostoula A; Hasiotis G; Achimastos A; Ganotakis E; Elisaf M; Mikhailidis DP
J Cardiovasc Pharmacol Ther; 2003 Jun; 8(2):127-34. PubMed ID: 12808486
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide mediated venodilator effects of nebivolol.
Bowman AJ; Chen CP; Ford GA
Br J Clin Pharmacol; 1994 Sep; 38(3):199-204. PubMed ID: 7826820
[TBL] [Abstract][Full Text] [Related]
17. Nebivolol: a third-generation beta-blocker for hypertension.
Cheng JW
Clin Ther; 2009 Mar; 31(3):447-62. PubMed ID: 19393838
[TBL] [Abstract][Full Text] [Related]
18. Effect of nebivolol, a novel beta 1-selective adrenoceptor antagonist with vasodilating properties, on kidney function.
Greven J; Gabriëls G
Arzneimittelforschung; 2000 Nov; 50(11):973-9. PubMed ID: 11148863
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of importance of central effects of atenolol and metoprolol measured by heart rate variability during mental performance tasks, physical exercise, and daily life in stable postinfarct patients.
Tuininga YS; Crijns HJ; Brouwer J; van den Berg MP; Man in't Veld AJ; Mulder G; Lie KI
Circulation; 1995 Dec; 92(12):3415-23. PubMed ID: 8521562
[TBL] [Abstract][Full Text] [Related]
20. Long-term nebivolol administration reduces renal fibrosis and prevents endothelial dysfunction in rats with hypertension induced by renal mass reduction.
Pires MJ; Rodríguez-Peña AB; Arévalo M; Cenador B; Evangelista S; Esteller A; Sánchez-Rodríguez A; Colaço A; López-Novoa JM
J Hypertens; 2007 Dec; 25(12):2486-96. PubMed ID: 17984671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
